Literature DB >> 21293507

IBS in 2010: advances in pathophysiology, diagnosis and treatment.

Alexander C Ford1, Nicholas J Talley.   

Abstract

IBS is a chronic, fluctuating disorder that continues to be the subject of considerable research. 2010 saw some key advances across all aspects of IBS, including further advances in our understanding of the pathophysiology, diagnosis and treatment of this condition.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21293507     DOI： 10.1038/nrgastro.2010.216

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


  9 in total

1.  Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study.

Authors:  B Bonaz; M Baciu; E Papillon; R Bost; N Gueddah; J F Le Bas; J Fournet; C Segebarth
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

2.  The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial.

Authors:  William D Chey; Borko Nojkov; Joel H Rubenstein; Richard R Dobhan; Joel K Greenson; Brooks D Cash
Journal:  Am J Gastroenterol       Date:  2010-02-23       Impact factor: 10.864

3.  Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery.

Authors:  John K Marshall; Marroon Thabane; Amit X Garg; William F Clark; Paul Moayyedi; Stephen M Collins
Journal:  Gut       Date:  2010-05       Impact factor: 23.059

4.  The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome.

Authors:  Tamira K Klooker; Breg Braak; Karin E Koopman; Olaf Welting; Mira M Wouters; Sicco van der Heide; Michael Schemann; Stephan C Bischoff; Rene M van den Wijngaard; Guy E Boeckxstaens
Journal:  Gut       Date:  2010-07-21       Impact factor: 23.059

5.  Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention.

Authors:  H Mertz; V Morgan; G Tanner; D Pickens; R Price; Y Shyr; R Kessler
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

6.  Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation.

Authors:  Jeffrey M Johnston; Caroline B Kurtz; James E Macdougall; Bernard J Lavins; Mark G Currie; Donald A Fitch; Chris O'Dea; Mollie Baird; Anthony J Lembo
Journal:  Gastroenterology       Date:  2010-08-27       Impact factor: 22.682

7.  Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome.

Authors:  Kirsten Tillisch; Emeran A Mayer; Jennifer S Labus
Journal:  Gastroenterology       Date:  2010-08-07       Impact factor: 22.682

Review 8.  Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome.

Authors:  M Thabane; D T Kottachchi; J K Marshall
Journal:  Aliment Pharmacol Ther       Date:  2007-08-15       Impact factor: 8.171

9.  Efficacy of linaclotide for patients with chronic constipation.

Authors:  Anthony J Lembo; Caroline B Kurtz; James E Macdougall; B J Lavins; Mark G Currie; Donald A Fitch; Brenda I Jeglinski; Jeffrey M Johnston
Journal:  Gastroenterology       Date:  2010-01-04       Impact factor: 22.682
  9 in total
  11 in total

1.  Targeting ion channels for the treatment of gastrointestinal motility disorders.

Authors:  Arthur Beyder; Gianrico Farrugia
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

2.  Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome.

Authors:  Arthur Beyder; Amelia Mazzone; Peter R Strege; David J Tester; Yuri A Saito; Cheryl E Bernard; Felicity T Enders; Weronica E Ek; Peter T Schmidt; Aldona Dlugosz; Greger Lindberg; Pontus Karling; Bodil Ohlsson; Maria Gazouli; Gerardo Nardone; Rosario Cuomo; Paolo Usai-Satta; Francesca Galeazzi; Matteo Neri; Piero Portincasa; Massimo Bellini; Giovanni Barbara; Michael Camilleri; G Richard Locke; Nicholas J Talley; Mauro D'Amato; Michael J Ackerman; Gianrico Farrugia
Journal:  Gastroenterology       Date:  2014-03-05       Impact factor: 22.682

3.  Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome.

Authors:  Natalia Pedersen; Nynne Nyboe Andersen; Zsuzsanna Végh; Lisbeth Jensen; Dorit Vedel Ankersen; Maria Felding; Mette Hestetun Simonsen; Johan Burisch; Pia Munkholm
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

Review 4.  Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection.

Authors:  Jennifer K Beatty; Amol Bhargava; Andre G Buret
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

5.  Symptomatic fructose malabsorption in irritable bowel syndrome: A prospective study.

Authors:  Chloé Melchior; Guillaume Gourcerol; Pierre Déchelotte; Anne-Marie Leroi; Philippe Ducrotté
Journal:  United European Gastroenterol J       Date:  2014-04       Impact factor: 4.623

6.  The effect of topical local anesthetics on thermal pain sensitivity in patients with irritable bowel syndrome.

Authors:  Anthony Rodrigues; Christopher D King; Fong Wong; Joseph L Riley; Siegfried Schmidt; Andre P Mauderli
Journal:  Pain Res Treat       Date:  2012-02-28

Review 7.  Comparison between the Effects of Acupuncture Relative to Other Controls on Irritable Bowel Syndrome: A Meta-Analysis.

Authors:  Haizhen Zheng; Rixin Chen; Xiaofeng Zhao; Guanhui Li; Yi Liang; Hao Zhang; Zhenhai Chi
Journal:  Pain Res Manag       Date:  2019-11-11       Impact factor: 3.037

Review 8.  Efficacy and Safety of Acupoint Catgut Embedding for Diarrhea-Predominant Irritable Bowel Syndrome and Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Jing Wu; Qinwei Fu; Shasha Yang; Hui Wang; Yaofeng Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-11-27       Impact factor: 2.629

Review 9.  Moxibustion in the management of irritable bowel syndrome: systematic review and meta-analysis.

Authors:  Jae-Woo Park; Byung-Hee Lee; Hyangsook Lee
Journal:  BMC Complement Altern Med       Date:  2013-10-02       Impact factor: 3.659

10.  Quality of Evidence Supporting the Role of Acupuncture for the Treatment of Irritable Bowel Syndrome.

Authors:  Jinke Huang; Mengxiong Lu; Yijun Zheng; Jinxin Ma; Xiangxue Ma; Yitian Wang; Kunli Zhang; Fengyun Wang; Xudong Tang
Journal:  Pain Res Manag       Date:  2021-12-15       Impact factor: 3.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.